Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
Bourke
John P
JP
Freeman Hospital, Newcastle-upon-Tyne, UK.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000209:etiology / Q000517:prevention & control; D002462:Cell Membrane / Q000378:metabolism; D002648:Child; D016189:Dystrophin / Q000235:genetics / Q000378:metabolism; D006331:Heart Diseases / Q000209:etiology* / Q000517:prevention & control*; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D020388:Muscular Dystrophy, Duchenne / Q000150:complications* / Q000235:genetics; D010348:Patient Care Team; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D016189:Dystrophin